Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
523-534
Author(s):
J. Narashimamurthy, A. Raghu Ram Rao and G. Narahari Sastry
Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
459-470
Author(s):
Y. J. Ko and S. P. Balk
Cigarette Smoking, Metabolic Activation and Carcinogenesis
Journal:
Current Drug Metabolism
Volume:
5
Page:
363-373
Author(s):
Akiyoshi Nishikawa, Yukio Mori, In-Seon Lee, Takuji Tanaka and Masao Hirose
Metabonomics: Its Potential as a Tool in Toxicology for Safety Assessment and Data Integration
Journal:
Current Drug Metabolism
Volume:
5
Page:
389-398
Author(s):
J. L. Griffin and M. E. Bollard
Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Journal:
Current Drug Metabolism
Volume:
5
Page:
415-442
Author(s):
Shufeng Zhou, Eli Chan, Lee Yong Lim, Urs A. Boelsterli, Shu Chuen Li, Jiancheng Wang, Qiang Zhang, Min Huang and Anlong Xu
Eph Receptor Tyrosine Kinases in Tumor and Tumor Microenvironment
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3431-3442
Author(s):
Dana Brantley-Sieders, Sonja Schmidt, Monica Parker and Jin Chen
Cellular and Physiological Effects of Soy Flavonoids
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
881-887
Author(s):
Tatiana Valachovicova, Veronika Slivova and Daniel Sliva
Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
357-377
Author(s):
Keith J. Miller, Brian J. Murphy and Mary Ann Pelleymounter
Targeting Human Telomerase by Antisense Oligonucleotides and Ribozymes: An Update
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
413-417
Author(s):
M. Folini, M. Pennati and N. Zaffaroni
Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
471-482
Author(s):
E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis